Dopamine antagonist-induced reproductive function in anoestrous mares: gonadotrophin secretion and the effects of environmental cues.

This research article investigates how the dopamine antagonist sulpiride impacts the secretion of a specific hormone (FSH) linked to reproductive activity in mares that aren’t cycling (anoestrous). The study emphasizes that environmental conditions like light exposure and housing temperature can significantly interact with the drug’s effect, influencing when the mares ovulate.

Exploring the Effect of Dopamine Antagonist on FSH Secretion

• In the first experiment, the equivalently of 0.5 mg of sulpiride per kg of body mass was administered to anoestrous mares twice a day. The research team aimed to observe any alterations in the frequency of FSH pulses, the average and minimum FSH concentrations in the blood, and the amplitude (strength) of these pulses. The findings indicated that sulpiride treatment had no significant impact on these parameters.
• Because of these results, the researchers question a widely-accepted hypothesis that dopamine can inhibit reproductive activity in creatures by suppressing the secretion of GnRH, a hormone that regulates the release of FSH and other reproductive hormones.

Interplay of Environmental Factors and Dopamine Antagonist Treatment on Ovulation

• In the second and third experiments, they tested the effects of sulpiride treatment paired with varying environmental factors on the duration until first ovulation.
• The researchers found that the mares that received the sulpiride treatment in an extended daylength housing situation ovulated considerably earlier than untreated mares in similar light conditions, and those housed outside under natural light variations.
• The context is crucial, as the parameters of FSH secretion at the beginning of treatment can significantly affect the time until ovulation. If this element is factored in as a covariant, sulpiride’s impact becomes insignificant, suggesting that the environment can potentially overshadow the medication’s effects.
• However, when sulpiride was administered to mares outside and exposed to natural light and temperature conditions, there was no significant acceleration in ovulation, compared to untreated mares in the same living conditions.

Key Findings and Future Directions

• Overall, the research underscores the complex interactions between pharmaceutical interventions and environmental conditions on hormone-mediated processes such as ovulation.
• They found that a stimulating environment, characterized by extended periods of light and indoor temperature, resulted in shorter intervals to first ovulation when combined with sulpiride treatment.
• However, unsupportive environments can decrease the treatment’s effectiveness on the ovulation interval.
• One final aspect for future research is to ascertain the specific role of FSH secretion levels at the time of sulpiride treatment in determining the onset of ovulation.